EMLINO 25 mg + 5 mg is a combination tablet containing empagliflozin 25 mg and linagliptin 5 mg. It is an oral antidiabetic medicine used to help control blood glucose levels in adults with type 2 diabetes mellitus.
Uses:
-
Treatment of type 2 diabetes mellitus
-
Helps reduce high blood sugar levels
-
Improves glucose control along with diet and exercise
-
Reduces glucose reabsorption through the kidneys (empagliflozin effect)
-
Enhances insulin regulation and glucose-dependent insulin release (linagliptin effect)
Dose:
-
Adults: Usually 1 tablet once daily or as directed by a physician
-
May be taken with or without food
-
Take regularly at the same time each day
-
Follow the prescribed dose and duration as advised by a healthcare professional.